期刊
CELLULAR AND MOLECULAR NEUROBIOLOGY
卷 41, 期 7, 页码 1395-1411出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10571-020-00914-2
关键词
Parkinson's disease; Parkin; Mitochondrial biogenesis; Mitochondrial dynamics; Mitophagy
资金
- National Natural Science Foundation of China [81473376]
- Scientific Research In-depth Development Fund of Beijing University of Chinese Medicine [2019-ZXFZJJ-074]
- CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-004]
- Drug Innovation Major Project [2018ZX09711001-003-005, 2018ZX09711001-009-013]
Parkinson's disease, a complex neurodegenerative disorder affecting millions of aged individuals, has been linked to mitochondrial dysfunction. Mutations in genes associated with PD, such as Parkin, have been found to play a crucial role in mitochondrial quality control, suggesting potential therapeutic targets for the disease.
Parkinson's disease (PD), as one of the complex neurodegenerative disorders, affects millions of aged people. Although the precise pathogenesis remains mostly unknown, a significant number of studies have demonstrated that mitochondrial dysfunction acts as a major role in the pathogeny of PD. Both nuclear and mitochondrial DNA mutations can damage mitochondrial integrity. Especially, mutations in several genes that PD-linked have a closed association with mitochondrial dysfunction (e.g., Parkin, PINK1, DJ-1, alpha-synuclein, and LRRK2). Parkin, whose mutation causes autosomal-recessive juvenile parkinsonism, plays an essential role in mitochondrial quality control of mitochondrial biogenesis, mitochondrial dynamics, and mitophagy. Therefore, we summarized the advanced studies of Parkin's role in mitochondrial quality control and hoped it could be studied further as a therapeutic target for PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据